Alcon Inc.

Equities

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 03:22:28 2025-12-10 am EST			5-day change	1st Jan Change
63.80 ^CHF	-0.56%		-0.38%	-17.22%

01:11am	Swiss stocks - Factors to watch on December 10	RE
Dec. 09	Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical	DJ

Alcon shares rebound after solid third quarter

Alcon delivered slightly better-than-expected third-quarter results and confirmed its 2025 Guidance after two earlier downgrades, easing investor concerns. Strong momentum in new Surgical equipment and contact lenses is helping to offset competitive pressures in Implantables.

Published on 11/13/2025 at 12:08 pm EST - Modified on 11/13/2025 at 11:43 am EST

Alphavalue

This Alphavalue article, the European leader in independent research, is only available to subscribers .

Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!

Already a customer? Log In

Latest news about Alcon Inc.

01:11am	Swiss stocks - Factors to watch on December 10	RE
Dec. 09	Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical	DJ
Dec. 09	Broadwood Partners continues to urge Staarr shareholders to vote "against" proposed transaction with Alcon	RE
Dec. 09	Swiss Market Index Retreats; Swiss Re Shares Down	MT
Dec. 09	Staar Surgical Shares Surge as Alcon Boosts its Buyout Price	DJ
Dec. 09	Alcon Ups Takeover Bid for Staar Surgical Under Amended Merger Deal	MT
Dec. 09	Alcon Upgrades Offer Price for Staar Surgical	DJ
Dec. 09	Swiss eyecare giant Alcon lifts bid for rival Staar	RE
Dec. 09	Alcon Increases Bid to Acquire STAAR Surgical to $1.6 Billion	MT
Dec. 09	Alcon lifts offer for Staar Surgical merger to $1.6 billion	RE
Dec. 08	Sector Update: Health Care Stocks Fall Late Afternoon	MT
Dec. 08	STAAR Surgical Shareholder Broadwood Partners Reiterates Opposition to Alcon Transaction	MT
Dec. 08	STAAR Surgical Announces Expiration of Go-Shop Period	CI
Dec. 08	Sector Update: Health Care Stocks Lower in Afternoon Trading	MT
Dec. 08	Egan-Jones Issues Recommendations to Shareholders of STAAR Surgical Company	CI
Dec. 08	Sector Update: Health Care	MT
Dec. 08	STAAR Surgical Says Go-Shop Period in Alcon Deal Expires With No Competing Proposals	MT
Dec. 09	Deals of the day-Mergers and acquisitions	RE
Dec. 02	Personal Assets Trust net asset value rises amid gold and equity gains	AN
Nov. 13	Alcon shares rebound after solid third quarter
Nov. 13	Needham Trims Price Target on Alcon to $98 From $101, Keeps Buy Rating	MT
Nov. 13	RBC Slightly Lowers FY25 Estimates for Alcon After Q3 Update	MT
Nov. 12	Better times ahead for Alcon
Nov. 12	Alcon Inc., Q3 2025 Earnings Call, Nov 12, 2025
Nov. 12	Alcon Shares in Switzerland Climb After Guidance Confirmation	DJ

Chart Alcon Inc.

Duration

Period

ALC: Dynamic Chart

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.1%): consumables (51.8% of net sales), implantable products (32.1%) and other products (16.1%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.9%): contact lenses (60.5% of sales) and eye care products (39.5%; eye drops and ophthalmic ointments, etc.). At the end of 2024, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.8%), the United States (45.9%), China (5.7%), Japan (5.6%) and other (42%).

Employees

25,000

Sector

Medical Equipment, Supplies & Distribution

Calendar

Jan. 13 - J.P. Morgan Healthcare Conference

More about the company